Literature DB >> 18930398

2-Trifluoroacetylthiophene oxadiazoles as potent and selective class II human histone deacetylase inhibitors.

Ester Muraglia1, Sergio Altamura, Danila Branca, Ottavia Cecchetti, Federica Ferrigno, Maria Vittoria Orsale, Maria Cecilia Palumbi, Michael Rowley, Rita Scarpelli, Christian Steinkühler, Philip Jones.   

Abstract

Trifluoroacetylthiophene carboxamides have recently been reported to be class II HDAC inhibitors, with moderate selectivity. Exploration of replacements for the carboxamide with bioisosteric pentatomic heteroaromatic like 1,3,4-oxadiazoles, 1,2,4-oxadiazoles and 1,3-thiazoles, led to the discovery that 2-trifluoroacetylthiophene 1,3,4-oxadiazole derivatives are very potent low nanomolar HDAC4 inhibitors, highly selective over class I HDACs (HDAC 1 and 3), and moderately stable in HCT116 cell culture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18930398     DOI: 10.1016/j.bmcl.2008.09.076

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  9 in total

1.  Developing consensus 3D-QSAR and pharmacophore models for several beta-secretase, farnesyl transferase and histone deacetylase inhibitors.

Authors:  Hsin-Yuan Wei; Guan-Ju Chen; Chih-Lun Chen; Thy-Hou Lin
Journal:  J Mol Model       Date:  2011-05-12       Impact factor: 1.810

2.  Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.

Authors:  Jongmin Kim; Cheol Hwangbo; Xiaoyue Hu; Yujung Kang; Irinna Papangeli; Devi Mehrotra; Hyekyung Park; Hyekyung Ju; Danielle L McLean; Suzy A Comhair; Serpil C Erzurum; Hyung J Chun
Journal:  Circulation       Date:  2014-10-21       Impact factor: 29.690

3.  Promiscuous actions of small molecule inhibitors of the protein kinase D-class IIa HDAC axis in striated muscle.

Authors:  Douglas D Lemon; Brooke C Harrison; Todd R Horn; Matthew S Stratton; Bradley S Ferguson; Michael F Wempe; Timothy A McKinsey
Journal:  FEBS Lett       Date:  2015-03-25       Impact factor: 4.124

4.  Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors.

Authors:  Nancie M Archin; Kara S Keedy; Amy Espeseth; Herbert Dang; Daria J Hazuda; David M Margolis
Journal:  AIDS       Date:  2009-09-10       Impact factor: 4.177

Review 5.  Immunomodulatory effects of deacetylase inhibitors: therapeutic targeting of FOXP3+ regulatory T cells.

Authors:  Liqing Wang; Edwin F de Zoeten; Mark I Greene; Wayne W Hancock
Journal:  Nat Rev Drug Discov       Date:  2009-10-26       Impact factor: 84.694

6.  Synthesis and biological evaluation of largazole analogues with modified surface recognition cap groups.

Authors:  Pravin Bhansali; Christin L Hanigan; Lalith Perera; Robert A Casero; L M Viranga Tillekeratne
Journal:  Eur J Med Chem       Date:  2014-09-06       Impact factor: 6.514

7.  Assessment of the trifluoromethyl ketone functionality as an alternative zinc-binding group for selective HDAC6 inhibition.

Authors:  Yves Depetter; Silke Geurs; Flore Vanden Bussche; Rob De Vreese; Jorick Franceus; Tom Desmet; Olivier De Wever; Matthias D'hooghe
Journal:  Medchemcomm       Date:  2018-05-18       Impact factor: 3.597

8.  Oral administration of the pimelic diphenylamide HDAC inhibitor HDACi 4b is unsuitable for chronic inhibition of HDAC activity in the CNS in vivo.

Authors:  Maria Beconi; Omar Aziz; Kim Matthews; Lara Moumné; Catherine O'Connell; Dawn Yates; Steven Clifton; Hannah Pett; Julie Vann; Lynsey Crowley; Alan F Haughan; Donna L Smith; Ben Woodman; Gillian P Bates; Fred Brookfield; Roland W Bürli; George McAllister; Celia Dominguez; Ignacio Munoz-Sanjuan; Vahri Beaumont
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

9.  Search for the pharmacophore of histone deacetylase inhibitors using pharmacophore query and docking study.

Authors:  Atefeh Haji Agha Bozorgi; Afshin Zarghi
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.